Immune checkpoint inhibitors for patients with autoimmune bullous disease: Insights from a systematic review.
메타분석
2/5 보강
TL;DR
Though some patients ultimately achieved control of AIBD along with stable or responsive tumours, suggesting the potential benefits of ICI, it is cautioned that the high likelihood of disease exacerbation, particularly for lethal conditions like PNP, necessitates a careful risk–benefit assessment before initiating ICI in AIBD patients.
OpenAlex 토픽 ·
Autoimmune Bullous Skin Diseases
Infectious Diseases and Mycology
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Though some patients ultimately achieved control of AIBD along with stable or responsive tumours, suggesting the potential benefits of ICI, it is cautioned that the high likelihood of disease exacerba
APA
Min Zou, Jishu Li, et al. (2026). Immune checkpoint inhibitors for patients with autoimmune bullous disease: Insights from a systematic review.. Journal of the European Academy of Dermatology and Venereology : JEADV, 40(4), e239-e241. https://doi.org/10.1111/jdv.70007
MLA
Min Zou, et al.. "Immune checkpoint inhibitors for patients with autoimmune bullous disease: Insights from a systematic review.." Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 40, no. 4, 2026, pp. e239-e241.
PMID
40801106 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Immune Checkpoint Inhibitor-Related Bullous Pemphigoid: Distinct Clinical and Immunological Profiles.
- Autoimmune Bullous Diseases Associated With Immune Checkpoint Inhibitors: An Analysis Based on a Systematic Review.
- Advances in the near-infrared Ⅱ for in vivo fluorescence imaging applications: A review.
- Discovery and research progress of CDK8 inhibitors.
- Re-evaluating serum IL-6 as a prognostic biomarker in HCC immunotherapy with atezolizumab plus bevacizumab: the critical role of baseline liver function and disease etiology.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24).
- SLC2A1 tumour-associated macrophages spatially control CD8 T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.
- Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
- Successful Treatment of Paranasal Sinus Metastasis From Renal Cell Carcinoma With Immune Checkpoint Inhibitors and Radiotherapy: A Case Report.
- Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy.
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.